Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

How biopharmaceutical collaboration is driving a new era of medicine

September 7, 2017

Biopharmaceutical innovation and technological advancements are transforming how we research and develop new medicines to benefit patients.

Read More

Protect Your Health: Important Disaster Preparedness Tips for Harvey and Irma

September 6, 2017

Hurricane Irma is poised to make a hit on health care infrastructure. That’s why it’s crucial to create a disaster preparedness plan for your health care needs.

Read More

PhRMA and BIO Initiate Litigation to Challenge Unconstitutional Provisions of Nevada’s SB 539

September 1, 2017

Today, PhRMA and BIO initiated litigation challenging provisions of SB 539, a Nevada law that would violate patent rights and negate trade secret protection for designated diabetes medicines in a way that would harm patients and chill future biomedical innovation.

Read More

Helping those affected by the 2017 hurricane season

August 31, 2017

Helping those affected by the 2017 hurricane season

Read More

SB 17 doesn’t address pressing prescription drug transparency issues for CA voters

August 30, 2017

Does the promise of SB 17 align with the needs of Californians?

Read More

PhRMA Announces Dr. Richard Moscicki as New Chief Medical Officer and Executive Vice President

August 30, 2017

PhRMA today announced Richard A. Moscicki, M.D. will join the organization as chief medical officer and executive vice president.

Read More

Medicare Monday: Call for repeal of IPAB intensifies

August 28, 2017

A look at the growing bipartisan opposition to IPAB.

Read More

Medicare Monday: What is the Extra Help program?

August 21, 2017

Medicare Part D’s Extra Help program helps low-income beneficiaries better afford their medicines.

Read More

PhRMA Statement on President Trump’s Signing of PDUFA VI Reauthorization

August 18, 2017

PhRMA president and CEO Stephen J. Ubl issued the following statement.

Read More

Medicare Monday: Strengthening access to vaccines for seniors

August 14, 2017

Importance of access to vaccines for seniors

Read More